CDT Equity (CDT) EPS (Diluted) (2022 - 2026)
CDT Equity (CDT) EPS (Diluted) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.15 |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | -8.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -62.13 |
| Mar 31, 2026 | -55.53 |
| Dec 31, 2025 | -5,987.99 |
| Sep 30, 2025 | -3,335.64 |
| Jun 30, 2025 | -10,940.22 |
| Mar 31, 2025 | -36,215.38 |
| Dec 31, 2024 | -321,965.52 |
| Sep 30, 2024 | -224,793.10 |
| Jun 30, 2024 | -218,960.00 |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -40,826.09 |
| Sep 30, 2023 | -30,863.64 |
| Jun 30, 2023 | -343,711.00 |
| Mar 31, 2023 | 5,466.77 |
| Dec 31, 2022 | 46,900.67 |
| Sep 30, 2022 | 18,809.64 |
| Jun 30, 2022 | -23,507.80 |